Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets

Class:IdLiteratureReference:9932774
_displayNameSuper-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
_timestamp2024-12-20 20:36:31
author[Person:9932749] Qian, Haihong
[Person:9024871] Zhu, Min
[Person:9727928] Tan, Xinyu
[Person:9932761] Zhang, Yixing
[Person:9932743] Liu, Xiangning
[Person:5621757] Yang, Li
created[InstanceEdit:9932796] Rothfels, Karen, 2024-12-20
journalCell Death Discov
pages470
pubMedIdentifier38135679
titleSuper-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
volume9
year2023
(literatureReference)[Reaction:9932443] BICRA, BICRAL and BRD9 bind SMARCC dimer:SMARCDs [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets (9932774)